메뉴 건너뛰기




Volumn 68, Issue 7, 2016, Pages 1700-1710

Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3

(17)  Fussner, Lynn A a   Hummel, Amber M a   Schroeder, Darrell R a   Silva, Francisco b   Cartin Ceba, Rodrigo a   Snyder, Melissa R a   Hoffman, Gary S c   Kallenberg, Cees G M d   Langford, Carol A c   Merkel, Peter A e   Monach, Paul A f   Seo, Philip g   Spiera, Robert F h   William St Clair, E i   Tchao, Nadia K j   Stone, John H k   Specks, Ulrich a  


Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYCLOPHOSPHAMIDE; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE 3 NEUTROPHIL CYTOPLASMIC ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

EID: 84976547922     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39637     Document Type: Article
Times cited : (132)

References (52)
  • 1
    • 84871251698 scopus 로고    scopus 로고
    • 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
    • Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1–11.
    • (2013) Arthritis Rheum , vol.65 , pp. 1-11
    • Jennette, J.C.1    Falk, R.J.2    Bacon, P.A.3    Basu, N.4    Cid, M.C.5    Ferrario, F.6
  • 2
    • 84873734665 scopus 로고    scopus 로고
    • Clinical features and diagnosis of small-vessel vasculitis
    • Langford C. Clinical features and diagnosis of small-vessel vasculitis. Cleve Clin J Med 2012;79Suppl3:S3–7.
    • (2012) Cleve Clin J Med , vol.79Suppl3 , pp. 3-7
    • Langford, C.1
  • 3
    • 22244469119 scopus 로고    scopus 로고
    • Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)
    • Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, et al, for the WGET Research Group. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 2005;52:2168–78.
    • (2005) Arthritis Rheum , vol.52 , pp. 2168-2178
    • Seo, P.1    Min, Y.I.2    Holbrook, J.T.3    Hoffman, G.S.4    Merkel, P.A.5    Spiera, R.6
  • 5
    • 12544253745 scopus 로고    scopus 로고
    • Etanercept plus standard therapy for Wegener's granulomatosis
    • Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005;352:351–61.
    • (2005) N Engl J Med , vol.352 , pp. 351-361
  • 8
    • 0034044534 scopus 로고    scopus 로고
    • An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients
    • Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000;43:1021–32.
    • (2000) Arthritis Rheum , vol.43 , pp. 1021-1032
    • Reinhold-Keller, E.1    Beuge, N.2    Latza, U.3    de Groot, K.4    Rudert, H.5    Nolle, B.6
  • 9
    • 84924024749 scopus 로고    scopus 로고
    • Accurate relapse prediction in ANCA-associated vasculitis—the search for the Holy Grail
    • Specks U. Accurate relapse prediction in ANCA-associated vasculitis—the search for the Holy Grail. J Am Soc Nephrol 2015;26:505–7.
    • (2015) J Am Soc Nephrol , vol.26 , pp. 505-507
    • Specks, U.1
  • 10
    • 84920235395 scopus 로고
    • Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis
    • Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1:425–9.
    • (1985) Lancet , vol.1 , pp. 425-429
    • Van der Woude, F.J.1    Rasmussen, N.2    Lobatto, S.3    Wiik, A.4    Permin, H.5    van Es, L.A.6
  • 12
    • 0031658145 scopus 로고    scopus 로고
    • Antineutrophil cytoplasmic antibodies [review]
    • Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies [review]. Arthritis Rheum 1998;41:1521–37.
    • (1998) Arthritis Rheum , vol.41 , pp. 1521-1537
    • Hoffman, G.S.1    Specks, U.2
  • 13
    • 34250840592 scopus 로고    scopus 로고
    • ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis
    • Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA, et al, WGET Research Group. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med 2007;120:643.e9–14.
    • (2007) Am J Med , vol.120
    • Finkielman, J.D.1    Lee, A.S.2    Hummel, A.M.3    Viss, M.A.4    Jacob, G.L.5    Homburger, H.A.6
  • 14
  • 15
    • 84924061014 scopus 로고    scopus 로고
    • ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease
    • Kemna MJ, Damoiseaux J, Austen J, Winkens B, Peters J, van Paassen P, et al. ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. J Am Soc Nephrol 2015;26:537–42.
    • (2015) J Am Soc Nephrol , vol.26 , pp. 537-542
    • Kemna, M.J.1    Damoiseaux, J.2    Austen, J.3    Winkens, B.4    Peters, J.5    van Paassen, P.6
  • 16
    • 0024999139 scopus 로고
    • Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre
    • Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;336:709–11.
    • (1990) Lancet , vol.336 , pp. 709-711
    • Tervaert, J.W.1    Huitema, M.G.2    Hene, R.J.3    Sluiter, W.J.4    The, T.H.5    van der Hem, G.K.6
  • 17
    • 0025999667 scopus 로고
    • Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis
    • Gaskin G, Savage CO, Ryan JJ, Jones S, Rees AJ, Lockwood CM, et al. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991;6:689–94.
    • (1991) Nephrol Dial Transplant , vol.6 , pp. 689-694
    • Gaskin, G.1    Savage, C.O.2    Ryan, J.J.3    Jones, S.4    Rees, A.J.5    Lockwood, C.M.6
  • 18
    • 0026582593 scopus 로고
    • Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study
    • Pettersson E, Heigl Z. Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study. Clin Nephrol 1992;37:219–28.
    • (1992) Clin Nephrol , vol.37 , pp. 219-228
    • Pettersson, E.1    Heigl, Z.2
  • 19
    • 0027536455 scopus 로고
    • Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis
    • Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993;36:365–71.
    • (1993) Arthritis Rheum , vol.36 , pp. 365-371
    • Kerr, G.S.1    Fleisher, T.A.2    Hallahan, C.W.3    Leavitt, R.Y.4    Fauci, A.S.5    Hoffman, G.S.6
  • 20
  • 21
    • 0028821552 scopus 로고
    • ANCA and predicting relapse in systemic vasculitis
    • Jayne DR, Gaskin G, Pusey CD, Lockwood CM. ANCA and predicting relapse in systemic vasculitis. QJM 1995;88:127–33.
    • (1995) QJM , vol.88 , pp. 127-133
    • Jayne, D.R.1    Gaskin, G.2    Pusey, C.D.3    Lockwood, C.M.4
  • 22
    • 0033135768 scopus 로고    scopus 로고
    • Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis
    • Kyndt X, Reumaux D, Bridoux F, Tribout B, Bataille P, Hachulla E, et al. Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis. Am J Med 1999;106:527–33.
    • (1999) Am J Med , vol.106 , pp. 527-533
    • Kyndt, X.1    Reumaux, D.2    Bridoux, F.3    Tribout, B.4    Bataille, P.5    Hachulla, E.6
  • 23
    • 0033711858 scopus 로고    scopus 로고
    • Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study
    • Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, et al. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000;43:2025–33.
    • (2000) Arthritis Rheum , vol.43 , pp. 2025-2033
    • Boomsma, M.M.1    Stegeman, C.A.2    van der Leij, M.J.3    Oost, W.4    Hermans, J.5    Kallenberg, C.G.6
  • 24
    • 0035093413 scopus 로고    scopus 로고
    • Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study
    • Girard T, Mahr A, Noel LH, Cordier JF, Lesavre P, Andre MH, et al. Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study. Rheumatology (Oxford) 2001;40:147–51.
    • (2001) Rheumatology (Oxford) , vol.40 , pp. 147-151
    • Girard, T.1    Mahr, A.2    Noel, L.H.3    Cordier, J.F.4    Lesavre, P.5    Andre, M.H.6
  • 25
    • 0034870832 scopus 로고    scopus 로고
    • ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis
    • Nowack R, Grab I, Flores-Suarez LF, Schnulle P, Yard B, van der Woude FJ. ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2001;16:1631–7.
    • (2001) Nephrol Dial Transplant , vol.16 , pp. 1631-1637
    • Nowack, R.1    Grab, I.2    Flores-Suarez, L.F.3    Schnulle, P.4    Yard, B.5    van der Woude, F.J.6
  • 26
    • 0037338664 scopus 로고    scopus 로고
    • Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis
    • Han WK, Choi HK, Roth RM, McCluskey RT, Niles JL. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 2003;63:1079–85.
    • (2003) Kidney Int , vol.63 , pp. 1079-1085
    • Han, W.K.1    Choi, H.K.2    Roth, R.M.3    McCluskey, R.T.4    Niles, J.L.5
  • 27
    • 33745609792 scopus 로고    scopus 로고
    • Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment
    • Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology (Oxford) 2006;45:724–9.
    • (2006) Rheumatology (Oxford) , vol.45 , pp. 724-729
    • Sanders, J.S.1    Huitma, M.G.2    Kallenberg, C.G.3    Stegeman, C.A.4
  • 28
    • 58849085096 scopus 로고    scopus 로고
    • A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis
    • Damoiseaux J, Dahnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, et al. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis 2009;68:228–33.
    • (2009) Ann Rheum Dis , vol.68 , pp. 228-233
    • Damoiseaux, J.1    Dahnrich, C.2    Rosemann, A.3    Probst, C.4    Komorowski, L.5    Stegeman, C.A.6
  • 29
    • 70349395712 scopus 로고    scopus 로고
    • Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides
    • Terrier B, Saadoun D, Sene D, Ghillani P, Amoura Z, Deray G, et al. Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides. Ann Rheum Dis 2009;68:1564–71.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1564-1571
    • Terrier, B.1    Saadoun, D.2    Sene, D.3    Ghillani, P.4    Amoura, Z.5    Deray, G.6
  • 30
    • 84878412613 scopus 로고    scopus 로고
    • Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity
    • Rasmussen N, Salmela A, Ekstrand A, de Groot K, Gregorini G, Cohen Tervaert JW, et al. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity. Clin Exp Rheumatol 2013;31 Suppl 75:S38–44.
    • (2013) Clin Exp Rheumatol , vol.31 , pp. 38-44
    • Rasmussen, N.1    Salmela, A.2    Ekstrand, A.3    de Groot, K.4    Gregorini, G.5    Cohen Tervaert, J.W.6
  • 31
    • 84936877480 scopus 로고    scopus 로고
    • Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
    • Alberici F, Smith RM, Jones RB, Roberts DM, Willcocks LC, Chaudhry A, et al. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis. Rheumatology (Oxford) 2015;54:1153–60.
    • (2015) Rheumatology (Oxford) , vol.54 , pp. 1153-1160
    • Alberici, F.1    Smith, R.M.2    Jones, R.B.3    Roberts, D.M.4    Willcocks, L.C.5    Chaudhry, A.6
  • 32
    • 84891738003 scopus 로고    scopus 로고
    • Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients
    • Thai LH, Charles P, Resche-Rigon M, Desseaux K, Guillevin L. Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients. Autoimmun Rev 2014;13:313–8.
    • (2014) Autoimmun Rev , vol.13 , pp. 313-318
    • Thai, L.H.1    Charles, P.2    Resche-Rigon, M.3    Desseaux, K.4    Guillevin, L.5
  • 33
    • 29244461435 scopus 로고    scopus 로고
    • Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review
    • Birck R, Schmitt WH, Kaelsch IA, van der Woude FJ. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am J Kidney Dis 2006;47:15–23.
    • (2006) Am J Kidney Dis , vol.47 , pp. 15-23
    • Birck, R.1    Schmitt, W.H.2    Kaelsch, I.A.3    van der Woude, F.J.4
  • 34
    • 84855168545 scopus 로고    scopus 로고
    • Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis—a meta-analysis
    • Tomasson G, Grayson PC, Mahr AD, LaValley M, Merkel PA. Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis—a meta-analysis. Rheumatology (Oxford) 2012;51:100–9.
    • (2012) Rheumatology (Oxford) , vol.51 , pp. 100-109
    • Tomasson, G.1    Grayson, P.C.2    Mahr, A.D.3    LaValley, M.4    Merkel, P.A.5
  • 35
    • 0031844342 scopus 로고    scopus 로고
    • Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies
    • Franssen C, Gans R, Kallenberg C, Hageluken C, Hoorntje S. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med 1998;244:209–16.
    • (1998) J Intern Med , vol.244 , pp. 209-216
    • Franssen, C.1    Gans, R.2    Kallenberg, C.3    Hageluken, C.4    Hoorntje, S.5
  • 36
    • 27644437166 scopus 로고    scopus 로고
    • Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis
    • Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005;143:621–31.
    • (2005) Ann Intern Med , vol.143 , pp. 621-631
    • Hogan, S.L.1    Falk, R.J.2    Chin, H.3    Cai, J.4    Jennette, C.E.5    Jennette, J.C.6
  • 37
    • 84869025741 scopus 로고    scopus 로고
    • Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis
    • Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 2012;64:3452–62.
    • (2012) Arthritis Rheum , vol.64 , pp. 3452-3462
    • Lionaki, S.1    Blyth, E.R.2    Hogan, S.L.3    Hu, Y.4    Senior, B.A.5    Jennette, C.E.6
  • 38
    • 84899746274 scopus 로고    scopus 로고
    • Predictors of treatment resistance and relapse in Chinese patients with antineutrophil cytoplasmic antibody-associated disease
    • Cao Y, Tian Z, Li W, Ma L, Yu Y, Ren W. Predictors of treatment resistance and relapse in Chinese patients with antineutrophil cytoplasmic antibody-associated disease. J Rheumatol 2014;41:916–22.
    • (2014) J Rheumatol , vol.41 , pp. 916-922
    • Cao, Y.1    Tian, Z.2    Li, W.3    Ma, L.4    Yu, Y.5    Ren, W.6
  • 39
    • 0035053927 scopus 로고    scopus 로고
    • A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score
    • Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al, for the International Network for the Study of the Systemic Vasculitides (INSSYS). A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. Arthritis Rheum 2001;44:912–20.
    • (2001) Arthritis Rheum , vol.44 , pp. 912-920
    • Stone, J.H.1    Hoffman, G.S.2    Merkel, P.A.3    Min, Y.I.4    Uhlfelder, M.L.5    Hellmann, D.B.6
  • 40
    • 84929896074 scopus 로고    scopus 로고
    • Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody–associated vasculitis treated with glucocorticoids
    • Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, et al, for the Rituximab in ANCA-Associated Vasculitis–Immune Tolerance Network Research Group. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody–associated vasculitis treated with glucocorticoids. Arthritis Rheumatol 2015;67:1629–36.
    • (2015) Arthritis Rheumatol , vol.67 , pp. 1629-1636
    • Miloslavsky, E.M.1    Specks, U.2    Merkel, P.A.3    Seo, P.4    Spiera, R.5    Langford, C.A.6
  • 41
    • 0032004169 scopus 로고    scopus 로고
    • Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes
    • Sun J, Fass DN, Hudson JA, Viss MA, Wieslander J, Homburger HA, et al. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes. J Immunol Methods 1998;211:111–23.
    • (1998) J Immunol Methods , vol.211 , pp. 111-123
    • Sun, J.1    Fass, D.N.2    Hudson, J.A.3    Viss, M.A.4    Wieslander, J.5    Homburger, H.A.6
  • 44
    • 0036169352 scopus 로고    scopus 로고
    • Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis
    • Gisslen K, Wieslander J, Westberg G, Herlitz H. Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis. J Intern Med 2002;251:129–35.
    • (2002) J Intern Med , vol.251 , pp. 129-135
    • Gisslen, K.1    Wieslander, J.2    Westberg, G.3    Herlitz, H.4
  • 45
    • 0031819391 scopus 로고    scopus 로고
    • Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody
    • Westman KW, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, et al. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Kidney Int 1998;53:1230–6.
    • (1998) Kidney Int , vol.53 , pp. 1230-1236
    • Westman, K.W.1    Selga, D.2    Bygren, P.3    Segelmark, M.4    Baslund, B.5    Wiik, A.6
  • 46
    • 0025345612 scopus 로고
    • Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro
    • Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990;87:4115–9.
    • (1990) Proc Natl Acad Sci U S A , vol.87 , pp. 4115-4119
    • Falk, R.J.1    Terrell, R.S.2    Charles, L.A.3    Jennette, J.C.4
  • 47
    • 0035040674 scopus 로고    scopus 로고
    • Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1
    • Taekema-Roelvink ME, Kooten C, Kooij SV, Heemskerk E, Daha MR. Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. J Am Soc Nephrol 2001;12:932–40.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 932-940
    • Taekema-Roelvink, M.E.1    Kooten, C.2    Kooij, S.V.3    Heemskerk, E.4    Daha, M.R.5
  • 49
    • 84855674846 scopus 로고    scopus 로고
    • Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system
    • Little MA, Al-Ani B, Ren S, Al-Nuaimi H, Leite M Jr, Alpers CE, et al. Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PLoS One 2012;7:e28626.
    • (2012) PLoS One , vol.7
    • Little, M.A.1    Al-Ani, B.2    Ren, S.3    Al-Nuaimi, H.4    Leite, M.5    Alpers, C.E.6
  • 51
    • 84868012506 scopus 로고    scopus 로고
    • Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center
    • Cartin-Ceba R, Golbin JM, Keogh KA, Peikert T, Sanchez-Menendez M, Ytterberg SR, et al. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center. Arthritis Rheum 2012;64:3770–8.
    • (2012) Arthritis Rheum , vol.64 , pp. 3770-3778
    • Cartin-Ceba, R.1    Golbin, J.M.2    Keogh, K.A.3    Peikert, T.4    Sanchez-Menendez, M.5    Ytterberg, S.R.6
  • 52
    • 84884702083 scopus 로고    scopus 로고
    • Performance evaluation of three assays for the detection of PR3-ANCA in granulomatosis with polyangiitis in daily practice
    • Noel N, Andre C, Bengoufa D, Dehoulle C, Mahler M, Limal N, et al. Performance evaluation of three assays for the detection of PR3-ANCA in granulomatosis with polyangiitis in daily practice. Autoimmun Rev 2013;12:1118–22.
    • (2013) Autoimmun Rev , vol.12 , pp. 1118-1122
    • Noel, N.1    Andre, C.2    Bengoufa, D.3    Dehoulle, C.4    Mahler, M.5    Limal, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.